Evidence map›Paper›PMID 15186569›Full record

SynthesisThe British journal of general practice : the journal of the Royal College of General Practitioners2004

Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness.

Christopher G Owen, Anupa Shah, Katherine Henshaw, Liam Smeeth, Aziz Sheikh

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The British journal of general practice : the journal of the Royal College of General Practitioners, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. BSACI guidelines for the management of allergic and non-allergic rhinitis.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2008
    Guideline
  3. Pooled it
  4. H1-antihistamines for the treatment of anaphylaxis with and without shock.The Cochrane database of systematic reviews · 2007
    Pooled it
  5. Trial
  6. Review
  7. Article
  8. Therapeutic Targets in Allergic Conjunctivitis.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. [Vernal keratoconjunctivitis].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2015
    Article
  14. Article
  15. Modern approach to managing vernal keratoconjunctivitis.Current allergy and asthma reports · 2010
    Article
  16. Hayfever--practical management issues.The British journal of general practice : the journal of the Royal College of General Practitioners · 2004
    Article
  17. Conjunctivitis: A Systematic Review.Journal of ophthalmic & vision research
    Review
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Christopher G OwenDepartment of Community Health Sciences, St George's Hospital Medical School, London. c.woen@sghms.ac.uk
Anupa Shah
Katherine Henshaw
Liam Smeeth
Aziz Sheikh
St George's, University of London · GB

Funding

Medical Research Council G108/492
6 · The paper itself

Abstract

backgroundEvidence for the effectiveness of topical treatments, in providing symptomatic relief from ocular allergy, remains uncertain.

aimsTo assess the effectiveness and relative efficacy of topical treatments for the management of seasonal allergic conjunctivitis. DESIGN OF STUDY: A systematic review and meta-analysis.

settingA literature search of the Cochrane Library, Medline, and EMBASE bibliographic databases.

methodDouble-masked randomised controlled trials were identified, that compared the use of topical mast cell stabilisers (sodium cromoglycate, nedocromil, lodoxamide) with placebo, topical antihistamines with placebo, and topical mast cell stabilisers with topical antihistamines.

resultsA meta-analysis of six trials showed that patients using sodium cromoglycate were 17 times (95% confidence interval [CI] = 4 to 78) more likely to perceive benefit compared with those using a placebo, although this estimate may be partially influenced by publication bias. Five trials indicated that those patients using nedocromil were 1.8 times (95% CI = 1.3 to 2.6) more likely to perceive their allergy to be moderately or totally controlled than those using a placebo. Four trials showed that those using antihistamines were 1.3 times (95% CI = 0.8 to 2.2) more likely to perceive a 'good' treatment effect than those using mast cell stabilisers, although this beneficial effect was not statistically significant. Limited evidence suggests that antihistamines might have a faster therapeutic effect compared to mast cell stabilisers.

conclusionOverall, these findings confirm the benefit of topical mast cell stabilisers and antihistamines over placebo for the treatment of allergic conjunctivitis. There is, however, insufficient evidence to recommend the use of one type of medication over another. Treatment preferences should therefore be based on convenience of use (with reduced frequency of instillation for some preparations), patient preference, and costs, especially as important side effects were not reported with any medication.

Indexed as

Administration, TopicalConjunctivitis, AllergicCross-Sectional StudiesHistamine H1 AntagonistsHumansMast CellsRandomized Controlled Trials as TopicRespiratory System AgentsSeasonsTreatment OutcomeHistamine H1 AntagonistsRespiratory System Agents

Identifiers

PMID15186569
PMCPMC1266207
OpenAlexW2142168476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.